Zilretta Labeling Updated to Include Information Pertaining to Repeat Administration
MPR,
The Food and Drug Administration has approved a supplemental New Drug Application (sNDA) to update the product labeling for…
The Food and Drug Administration has approved a supplemental New Drug Application (sNDA) to update the product labeling for…
TORONTO – The barren pharmacologic landscape in osteoarthritis today is reminiscent of rheumatoid arthritis 30 years ago: few…
Dr. Spitzer Co-director Joint Replacement Program Cedars-Sinai Orthopedic Center Los Angeles, CA Many patients receive repeat…
Company reported net ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension) sales of $22.5 million for full…